Investigating dose finding methods and different priors in Bayesian continual reassessment method
Clinical trials are studies that explore whether a treatment, drug or device is safe and effective for humans. These studies can show which medial method work best for certain diseases. A well-designed and a properly-analyzed clinical trial is a powerful tool for the development of new drugs. The f...
Saved in:
| Main Authors: | Tuba Koc, Mehmet Ali Cengiz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-01-01
|
| Series: | Kuwait Journal of Science |
| Subjects: | |
| Online Access: | https://journalskuwait.org/kjs/index.php/KJS/article/view/4087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comprehensive comparison of phase I dose escalation methods
by: Efehan Ulas, et al.
Published: (2018-11-01) -
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial
by: Charlotte Gaskell, et al.
Published: (2025-05-01) -
Navigating challenges in pediatric trial conduct: integrating bayesian sequential design with semiparametric elicitation for handling primary and secondary endpoints
by: Danila Azzolina, et al.
Published: (2025-03-01) -
Comparison Among Modified Continual Reassessment Methods with Different Dose Allocation Methods for Phase I Clinical Trials
by: Jiacheng Xiao, et al.
Published: (2025-03-01) -
Bayesian-frequentist hybrid inference framework for single cell RNA-seq analyses
by: Gang Han, et al.
Published: (2024-06-01)